Pricing Log in Create free account

Vaxcyte, Inc. (PCVX) vs Bio-Techne Corp (TECH)

Vaxcyte, Inc. and Bio-Techne Corp are both Biotechnology companies. Bio-Techne Corp is the larger, with a market value of $11.4B against $9.8B — 1.2× the size. Vaxcyte, Inc. has negative trailing earnings, so its P/E is not meaningful; Bio-Techne Corp trades at 66.2×. Bio-Techne Corp has the higher net margin (14.0% vs 0.00%) and the higher return on invested capital (8.29% vs −59.5%). Across the 15 metrics below, Bio-Techne Corp leads on 13 and Vaxcyte, Inc. on 2.

Valuation

Metric PCVX TECH Biotechnology median
P/E n/m 66.17 10.60
P/S n/m 9.29 9.40
P/B 3.82 5.27 2.13
Price to free cash flow n/m 37.03 25.18
EV/EBITDA n/m 33.40 0.66
EV/Sales n/m 9.18 9.02
Earnings yield (12.64%) 1.51% (32.88%)
Free cash flow yield (10.25%) 2.70% (23.13%)

Profitability

Metric PCVX TECH Biotechnology median
Gross margin 0.00% 65.75% 68.51%
Operating margin 0.00% 19.61% 0.00%
Net margin 0.00% 14.00% 0.00%
Free cash flow margin 0.00% 25.09% 0.00%
Return on equity (42.68%) 8.32% (51.96%)
Return on assets (37.28%) 6.66% (46.06%)
Return on invested capital (59.47%) 8.29% 0.00%

Growth

Metric PCVX TECH Biotechnology median
Revenue growth (TTM) — 0.94% 6.76%
EPS growth (last fiscal year) (48.16%) 152.17% 29.88%
Revenue growth, 5-year CAGR — 5.47% 9.75%
Net income growth, 5-year CAGR 0.00% 5.31% 0.00%

Health

Metric PCVX TECH Biotechnology median
Debt to equity 0.04 0.00 0.00
Current ratio 4.56 2.28 4.97
Net debt to EBITDA 1.71 (0.19) 1.01

Dividend

Metric PCVX TECH Biotechnology median
Dividend yield — 0.44% 0.41%
Payout ratio — 0.29 —

Size

Metric PCVX TECH Biotechnology median
Market cap 9.75b 11.41b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack